TTR and polyneuropathy: Of note, the use of instrumental biomarkers for the evaluation of tissue damage in ATTRv might lead to a higher sensitive and specific approach; moreover, these biomarkers might contribute to detecting the exact clinical onset of the disease in carriers of TTR mutation, giving them the opportunity to be treated early when the polyneuropathy starts.